# FZATA, INC.: Gut-Targeted IL-10 Delivery via Engineered Saccharomyces boulardii to Prevent Immune Checkpoint Inhibitor Colitis

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | FZATA, INC. |
| Location | HALETHORPE, MD |
| Project | Gut-Targeted IL-10 Delivery via Engineered Saccharomyces boulardii to Prevent Immune Checkpoint Inhibitor Colitis |
| Project number | 1R44DK146567-01 |
| Mechanism | R44 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $372,153 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-21 to 2027-08-31 |
| UEI | SLGDVHJS1Y85 |

## Why this score
- Award of $372,153.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11314083). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.